97TH GENERAL ASSEMBLY
State of Illinois
2011 and 2012
HB2089

 

Introduced 2/22/2011, by Rep. Wayne Rosenthal

 

SYNOPSIS AS INTRODUCED:
 
720 ILCS 570/204  from Ch. 56 1/2, par. 1204

    Amends the Illinois Controlled Substances Act. Adds MDPV to the list of Schedule I controlled substances. Effective immediately.


LRB097 08999 RLC 49133 b

CORRECTIONAL BUDGET AND IMPACT NOTE ACT MAY APPLY

 

 

A BILL FOR

 

HB2089LRB097 08999 RLC 49133 b

1    AN ACT concerning criminal law.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Illinois Controlled Substances Act is
5amended by changing Section 204 as follows:
 
6    (720 ILCS 570/204)  (from Ch. 56 1/2, par. 1204)
7    Sec. 204. (a) The controlled substances listed in this
8Section are included in Schedule I.
9    (b) Unless specifically excepted or unless listed in
10another schedule, any of the following opiates, including their
11isomers, esters, ethers, salts, and salts of isomers, esters,
12and ethers, whenever the existence of such isomers, esters,
13ethers and salts is possible within the specific chemical
14designation:
15        (1) Acetylmethadol;
16        (1.1) Acetyl-alpha-methylfentanyl
17    (N-[1-(1-methyl-2-phenethyl)-
18    4-piperidinyl]-N-phenylacetamide);
19        (2) Allylprodine;
20        (3) Alphacetylmethadol, except
21    levo-alphacetylmethadol (also known as levo-alpha-
22    acetylmethadol, levomethadyl acetate, or LAAM);
23        (4) Alphameprodine;

 

 

HB2089- 2 -LRB097 08999 RLC 49133 b

1        (5) Alphamethadol;
2        (6) Alpha-methylfentanyl
3    (N-(1-alpha-methyl-beta-phenyl) ethyl-4-piperidyl)
4    propionanilide;  1-(1-methyl-2-phenylethyl)-4-(N-
5    propanilido) piperidine;
6        (6.1) Alpha-methylthiofentanyl
7    (N-[1-methyl-2-(2-thienyl)ethyl-
8    4-piperidinyl]-N-phenylpropanamide);
9        (7) 1-methyl-4-phenyl-4-propionoxypiperidine (MPPP);
10        (7.1) PEPAP
11    (1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine);
12        (8) Benzethidine;
13        (9) Betacetylmethadol;
14        (9.1) Beta-hydroxyfentanyl
15    (N-[1-(2-hydroxy-2-phenethyl)-
16    4-piperidinyl]-N-phenylpropanamide);
17        (10) Betameprodine;
18        (11) Betamethadol;
19        (12) Betaprodine;
20        (13) Clonitazene;
21        (14) Dextromoramide;
22        (15) Diampromide;
23        (16) Diethylthiambutene;
24        (17) Difenoxin;
25        (18) Dimenoxadol;
26        (19) Dimepheptanol;

 

 

HB2089- 3 -LRB097 08999 RLC 49133 b

1        (20) Dimethylthiambutene;
2        (21) Dioxaphetylbutyrate;
3        (22) Dipipanone;
4        (23) Ethylmethylthiambutene;
5        (24) Etonitazene;
6        (25) Etoxeridine;
7        (26) Furethidine;
8        (27) Hydroxpethidine;
9        (28) Ketobemidone;
10        (29) Levomoramide;
11        (30) Levophenacylmorphan;
12        (31) 3-Methylfentanyl
13    (N-[3-methyl-1-(2-phenylethyl)-
14    4-piperidyl]-N-phenylpropanamide);
15        (31.1) 3-Methylthiofentanyl
16    (N-[(3-methyl-1-(2-thienyl)ethyl-
17    4-piperidinyl]-N-phenylpropanamide);
18        (32) Morpheridine;
19        (33) Noracymethadol;
20        (34) Norlevorphanol;
21        (35) Normethadone;
22        (36) Norpipanone;
23        (36.1) Para-fluorofentanyl
24    (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-
25    4-piperidinyl]propanamide);
26        (37) Phenadoxone;

 

 

HB2089- 4 -LRB097 08999 RLC 49133 b

1        (38) Phenampromide;
2        (39) Phenomorphan;
3        (40) Phenoperidine;
4        (41) Piritramide;
5        (42) Proheptazine;
6        (43) Properidine;
7        (44) Propiram;
8        (45) Racemoramide;
9        (45.1) Thiofentanyl
10    (N-phenyl-N-[1-(2-thienyl)ethyl-
11    4-piperidinyl]-propanamide);
12        (46) Tilidine;
13        (47) Trimeperidine;
14        (48) Beta-hydroxy-3-methylfentanyl (other name:
15    N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-
16    N-phenylpropanamide).
17    (c) Unless specifically excepted or unless listed in
18another schedule, any of the following opium derivatives, its
19salts, isomers and salts of isomers, whenever the existence of
20such salts, isomers and salts of isomers is possible within the
21specific chemical designation:
22        (1) Acetorphine;
23        (2) Acetyldihydrocodeine;
24        (3) Benzylmorphine;
25        (4) Codeine methylbromide;
26        (5) Codeine-N-Oxide;

 

 

HB2089- 5 -LRB097 08999 RLC 49133 b

1        (6) Cyprenorphine;
2        (7) Desomorphine;
3        (8) Diacetyldihydromorphine (Dihydroheroin);
4        (9) Dihydromorphine;
5        (10) Drotebanol;
6        (11) Etorphine (except hydrochloride salt);
7        (12) Heroin;
8        (13) Hydromorphinol;
9        (14) Methyldesorphine;
10        (15) Methyldihydromorphine;
11        (16) Morphine methylbromide;
12        (17) Morphine methylsulfonate;
13        (18) Morphine-N-Oxide;
14        (19) Myrophine;
15        (20) Nicocodeine;
16        (21) Nicomorphine;
17        (22) Normorphine;
18        (23) Pholcodine;
19        (24) Thebacon.
20    (d) Unless specifically excepted or unless listed in
21another schedule, any material, compound, mixture, or
22preparation which contains any quantity of the following
23hallucinogenic substances, or which contains any of its salts,
24isomers and salts of isomers, whenever the existence of such
25salts, isomers, and salts of isomers is possible within the
26specific chemical designation (for the purposes of this

 

 

HB2089- 6 -LRB097 08999 RLC 49133 b

1paragraph only, the term "isomer" includes the optical,
2position and geometric isomers):
3        (1) 3,4-methylenedioxyamphetamine
4    (alpha-methyl,3,4-methylenedioxyphenethylamine,
5    methylenedioxyamphetamine, MDA);
6        (1.1) Alpha-ethyltryptamine
7    (some trade or other names: etryptamine;
8    MONASE; alpha-ethyl-1H-indole-3-ethanamine;
9    3-(2-aminobutyl)indole; a-ET; and AET);
10        (2) 3,4-methylenedioxymethamphetamine (MDMA);
11        (2.1) 3,4-methylenedioxy-N-ethylamphetamine
12    (also known as: N-ethyl-alpha-methyl-
13    3,4(methylenedioxy) Phenethylamine, N-ethyl MDA, MDE,
14    and MDEA);
15        (2.2) N-Benzylpiperazine (BZP);
16        (3) 3-methoxy-4,5-methylenedioxyamphetamine, (MMDA);
17        (4) 3,4,5-trimethoxyamphetamine (TMA);
18        (5) (Blank);
19        (6) Diethyltryptamine (DET);
20        (7) Dimethyltryptamine (DMT);
21        (8) 4-methyl-2,5-dimethoxyamphetamine (DOM, STP);
22        (9) Ibogaine  (some trade and other names:
23    7-ethyl-6,6,beta,7,8,9,10,12,13-octahydro-2-methoxy-
24    6,9-methano-5H-pyrido [1',2':1,2] azepino [5,4-b]
25    indole; Tabernanthe iboga);
26        (10) Lysergic acid diethylamide;

 

 

HB2089- 7 -LRB097 08999 RLC 49133 b

1        (10.5) Salvia divinorum (meaning all parts of the plant
2    presently classified botanically as Salvia divinorum,
3    whether growing or not, the seeds thereof, any extract from
4    any part of that plant, and every compound, manufacture,
5    salts, isomers, and salts of isomers whenever the existence
6    of such salts, isomers, and salts of isomers is possible
7    within the specific chemical designation, derivative,
8    mixture, or preparation of that plant, its seeds or
9    extracts);
10        (11) 3,4,5-trimethoxyphenethylamine (Mescaline);
11        (12) Peyote (meaning all parts of the plant presently
12    classified botanically as Lophophora williamsii Lemaire,
13    whether growing or not, the seeds thereof, any extract from
14    any part of that plant, and every compound, manufacture,
15    salts, derivative, mixture, or preparation of that plant,
16    its seeds or extracts);
17        (13) N-ethyl-3-piperidyl benzilate (JB 318);
18        (14) N-methyl-3-piperidyl benzilate;
19        (14.1) N-hydroxy-3,4-methylenedioxyamphetamine
20    (also known as N-hydroxy-alpha-methyl-
21    3,4(methylenedioxy)phenethylamine and N-hydroxy MDA);
22        (15) Parahexyl; some trade or other names:
23    3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-
24    dibenzo (b,d) pyran; Synhexyl;
25        (16) Psilocybin;
26        (17) Psilocyn;

 

 

HB2089- 8 -LRB097 08999 RLC 49133 b

1        (18) Alpha-methyltryptamine (AMT);
2        (19) 2,5-dimethoxyamphetamine
3    (2,5-dimethoxy-alpha-methylphenethylamine; 2,5-DMA);
4        (20) 4-bromo-2,5-dimethoxyamphetamine
5    (4-bromo-2,5-dimethoxy-alpha-methylphenethylamine;
6    4-bromo-2,5-DMA);
7        (20.1) 4-Bromo-2,5 dimethoxyphenethylamine.
8    Some trade or other names: 2-(4-bromo-
9    2,5-dimethoxyphenyl)-1-aminoethane;
10    alpha-desmethyl DOB, 2CB, Nexus;
11        (21) 4-methoxyamphetamine
12    (4-methoxy-alpha-methylphenethylamine;
13    paramethoxyamphetamine; PMA);
14        (22) (Blank);
15        (23) Ethylamine analog of phencyclidine.
16    Some trade or other names:
17    N-ethyl-1-phenylcyclohexylamine,
18    (1-phenylcyclohexyl) ethylamine,
19    N-(1-phenylcyclohexyl) ethylamine, cyclohexamine, PCE;
20        (24) Pyrrolidine analog of phencyclidine. Some trade
21    or other names: 1-(1-phenylcyclohexyl) pyrrolidine, PCPy,
22    PHP;
23        (25) 5-methoxy-3,4-methylenedioxy-amphetamine;
24        (26) 2,5-dimethoxy-4-ethylamphetamine
25    (another name: DOET);
26        (27) 1-[1-(2-thienyl)cyclohexyl] pyrrolidine

 

 

HB2089- 9 -LRB097 08999 RLC 49133 b

1    (another name: TCPy);
2        (28) (Blank);
3        (29) Thiophene analog of phencyclidine (some trade
4    or other names: 1-[1-(2-thienyl)-cyclohexyl]-piperidine;
5    2-thienyl analog of phencyclidine; TPCP; TCP);
6        (30) Bufotenine (some trade or other names:
7    3-(Beta-Dimethylaminoethyl)-5-hydroxyindole;
8    3-(2-dimethylaminoethyl)-5-indolol;
9    5-hydroxy-N,N-dimethyltryptamine;
10    N,N-dimethylserotonin; mappine);
11        (31)  1-Pentyl-3-(1-naphthoyl)indole 
12    Some trade or other names: JWH-018; 
13        (32) 1-Butyl-3-(1-naphthoyl)indole 
14    Some trade or other names: JWH-073. 
15    (e) Unless specifically excepted or unless listed in
16another schedule, any material, compound, mixture, or
17preparation which contains any quantity of the following
18substances having a depressant effect on the central nervous
19system, including its salts, isomers, and salts of isomers
20whenever the existence of such salts, isomers, and salts of
21isomers is possible within the specific chemical designation:
22        (1) mecloqualone;
23        (2) methaqualone; and
24        (3) gamma hydroxybutyric acid.
25    (f) Unless specifically excepted or unless listed in
26another schedule, any material, compound, mixture, or

 

 

HB2089- 10 -LRB097 08999 RLC 49133 b

1preparation which contains any quantity of the following
2substances having a stimulant effect on the central nervous
3system, including its salts, isomers, and salts of isomers:
4        (1) Fenethylline;
5        (2) N-ethylamphetamine;
6        (3) Aminorex (some other names:
7    2-amino-5-phenyl-2-oxazoline; aminoxaphen;
8    4-5-dihydro-5-phenyl-2-oxazolamine) and its
9    salts, optical isomers, and salts of optical isomers;
10        (4) Methcathinone (some other names:
11    2-methylamino-1-phenylpropan-1-one;
12    Ephedrone; 2-(methylamino)-propiophenone;
13    alpha-(methylamino)propiophenone; N-methylcathinone;
14    methycathinone; Monomethylpropion; UR 1431) and its
15    salts, optical isomers, and salts of optical isomers;
16        (5) Cathinone (some trade or other names:
17    2-aminopropiophenone; alpha-aminopropiophenone;
18    2-amino-1-phenyl-propanone; norephedrone);
19        (6) N,N-dimethylamphetamine (also known as:
20    N,N-alpha-trimethyl-benzeneethanamine;
21    N,N-alpha-trimethylphenethylamine);
22        (7) (+ or -) cis-4-methylaminorex  ((+ or -) cis-
23    4,5-dihydro-4-methyl-4-5-phenyl-2-oxazolamine); .
24        (8) 3,4-Methylenedioxypyrovalerone (MDPV).
25    (g) Temporary listing of substances subject to emergency
26scheduling. Any material, compound, mixture, or preparation

 

 

HB2089- 11 -LRB097 08999 RLC 49133 b

1that contains any quantity of the following substances:
2        (1) N-[1-benzyl-4-piperidyl]-N-phenylpropanamide
3    (benzylfentanyl), its optical isomers, isomers, salts,
4    and salts of isomers;
5        (2) N-[1(2-thienyl)
6   methyl-4-piperidyl]-N-phenylpropanamide (thenylfentanyl),
7   its optical isomers, salts, and salts of isomers.
8(Source: P.A. 95-239, eff. 1-1-08; 95-331, eff. 8-21-07;
996-347, eff. 1-1-10; 96-1285, eff. 1-1-11.)
 
10    Section 99. Effective date. This Act takes effect upon
11becoming law.